Pros and cons of vaccination against serogroup B meningococcal disease.
Sign Up to like & getrecommendations! Published in 2018 at "Medicina Clinica"
DOI: 10.1016/j.medcli.2017.07.018
Abstract: A vaccine has recently been approved in the EU against meningococcal serogroup B, the main cause of meningococcal disease. There is a fierce debate about the decision regarding a universal vaccination in infants older than… read more here.
Keywords: disease; universal vaccination; pros cons; vaccination ... See more keywords